• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环微RNA可区分儿童川崎病与感染性发热疾病。

Circulating microRNAs differentiate Kawasaki Disease from infectious febrile illnesses in childhood.

作者信息

Jone Pei-Ni, Korst Armin, Karimpour-Fard Anis, Thomas Thomas, Dominguez Samuel R, Heizer Heather, Anderson Marsha S, Glode Mary P, Sucharov Carmen C, Miyamoto Shelley D

机构信息

Pediatric Cardiology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA.

Department of Medicine, University of Colorado Anschutz, Aurora, CO, USA.

出版信息

J Mol Cell Cardiol. 2020 Sep;146:12-18. doi: 10.1016/j.yjmcc.2020.06.011. Epub 2020 Jul 4.

DOI:10.1016/j.yjmcc.2020.06.011
PMID:32634388
Abstract

BACKGROUND

Kawasaki Disease (KD) is an acute vasculitis of unknown etiology in children that can lead to coronary artery lesions (CAL) in 25% of untreated patients. There is currently no diagnostic test for KD, and the clinical presentation is often difficult to differentiate from other febrile childhood illnesses. Circulating microRNAs (miRNAs) are small noncoding RNA molecules that control gene expression by inducing transcript degradation or by blocking translation. We hypothesize that the expression of circulating miRNAs will differentiate KD from non-KD febrile illnesses in children.

METHODS

Circulating miRNA profiles from 84 KD patients and 29 non-KD febrile controls (7 viral and 22 bacterial infections) were evaluated. 3 ul of serum from each subject was submitted to 3 freeze/heat cycles to ensure miRNA release from microvesicles or interaction with serum proteins. miRNAs were reverse transcribed using a pool of primers specific for each miRNA. Real-time PCR reactions were performed in a 384 well plate containing sequence-specific primers and TaqMan probes in the ABI7900. '.

RESULTS

KD patients (3.6 ± 2.2 yrs., 58% male) were found to have a unique circulating miRNA profile, including upregulation of miRNA-210-3p, -184, and -19a-3p (p < .0001), compared to non-KD febrile controls (8.5 ± 6.1 yrs., 72% male).

CONCLUSIONS

Circulating miRNAs can differentiate KD from infectious febrile childhood diseases, supporting their potential as a diagnostic biomarker for KD.

摘要

背景

川崎病(KD)是一种病因不明的儿童急性血管炎,在25%未经治疗的患者中可导致冠状动脉病变(CAL)。目前尚无针对KD的诊断测试,其临床表现往往难以与其他儿童发热性疾病相区分。循环微RNA(miRNA)是小的非编码RNA分子,通过诱导转录本降解或阻断翻译来控制基因表达。我们假设循环miRNA的表达将使KD与儿童非KD发热性疾病相区分。

方法

评估了84例KD患者和29例非KD发热对照(7例病毒感染和22例细菌感染)的循环miRNA谱。将每个受试者的3微升血清进行3次冻融循环,以确保miRNA从微泡中释放或与血清蛋白相互作用。使用针对每种miRNA的一组引物对miRNA进行逆转录。在含有序列特异性引物和TaqMan探针的384孔板中于ABI7900上进行实时PCR反应。

结果

发现KD患者(3.6±2.2岁,58%为男性)与非KD发热对照(8.5±6.1岁,72%为男性)相比,具有独特的循环miRNA谱,包括miRNA-210-3p、-184和-19a-3p上调(p<.0001)。

结论

循环miRNA可将KD与儿童感染性发热疾病区分开来,支持其作为KD诊断生物标志物的潜力。

相似文献

1
Circulating microRNAs differentiate Kawasaki Disease from infectious febrile illnesses in childhood.循环微RNA可区分儿童川崎病与感染性发热疾病。
J Mol Cell Cardiol. 2020 Sep;146:12-18. doi: 10.1016/j.yjmcc.2020.06.011. Epub 2020 Jul 4.
2
The Platelet microRNA Profile of Kawasaki Disease: Identification of Novel Diagnostic Biomarkers.川崎病的血小板 microRNA 谱:新型诊断生物标志物的鉴定。
Biomed Res Int. 2020 Jul 17;2020:9061568. doi: 10.1155/2020/9061568. eCollection 2020.
3
Diagnostic significance of circulating miRNAs in Kawasaki disease in China: Current evidence based on a meta-analysis.中国川崎病中循环微小RNA的诊断意义:基于荟萃分析的当前证据
Medicine (Baltimore). 2021 Feb 12;100(6):e24174. doi: 10.1097/MD.0000000000024174.
4
Fifteen-minute consultation: Kawasaki disease: how to distinguish from other febrile illnesses: tricks and tips.15 分钟会诊:川崎病:如何与其他发热性疾病相鉴别:技巧与窍门。
Arch Dis Child Educ Pract Ed. 2020 Jun;105(3):152-156. doi: 10.1136/archdischild-2019-316834. Epub 2020 Jan 3.
5
A Novel Truncated Form of Serum Amyloid A in Kawasaki Disease.川崎病中一种新型截短形式的血清淀粉样蛋白A
PLoS One. 2016 Jun 6;11(6):e0157024. doi: 10.1371/journal.pone.0157024. eCollection 2016.
6
Serum miR-92a-3p as a New Potential Biomarker for Diagnosis of Kawasaki Disease with Coronary Artery Lesions.血清miR-92a-3p作为诊断川崎病合并冠状动脉病变的新型潜在生物标志物。
J Cardiovasc Transl Res. 2017 Feb;10(1):1-8. doi: 10.1007/s12265-016-9717-x. Epub 2016 Dec 15.
7
Aberrant expression of serum circANRIL and hsa_circ_0123996 in children with Kawasaki disease.川崎病患儿血清 circANRIL 和 hsa_circ_0123996 的异常表达。
J Clin Lab Anal. 2019 Jun;33(5):e22874. doi: 10.1002/jcla.22874. Epub 2019 Mar 6.
8
Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children.糖基化终末产物前体(GlycA)和脂蛋白颗粒参数的差异可能有助于区分儿童急性川崎病与其他发热性疾病。
BMC Pediatr. 2016 Sep 5;16(1):151. doi: 10.1186/s12887-016-0688-5.
9
Serum exosomal microRNA let-7i-3p as candidate diagnostic biomarker for Kawasaki disease patients with coronary artery aneurysm.血清外泌体 microRNA let-7i-3p 作为川崎病合并冠状动脉瘤患者的候选诊断生物标志物。
IUBMB Life. 2019 Jul;71(7):891-900. doi: 10.1002/iub.2015. Epub 2019 Feb 6.
10
A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses.一种结合临床和分子数据的诊断算法可区分川崎病与其他发热性疾病。
BMC Med. 2011 Dec 6;9:130. doi: 10.1186/1741-7015-9-130.

引用本文的文献

1
Exploring the diagnostic value of CLR and CPR in differentiating Kawasaki disease from other infectious diseases based on clinical predictive modeling.基于临床预测模型探索CLR和CPR在鉴别川崎病与其他传染病中的诊断价值。
Front Pediatr. 2024 Feb 16;12:1345141. doi: 10.3389/fped.2024.1345141. eCollection 2024.
2
Circulating and Cardiac Tissue miRNAs in Children with Dilated Cardiomyopathy.扩张型心肌病患儿循环及心脏组织中的微小RNA
J Cardiovasc Dev Dis. 2023 Sep 11;10(9):391. doi: 10.3390/jcdd10090391.
3
CircRNA7632 down-regulation alleviates endothelial cell dysfunction in Kawasaki disease via regulating IL-33 expression.
环状 RNA7632 通过调控 IL-33 的表达缓解川崎病内皮细胞功能障碍。
Cell Stress Chaperones. 2023 Jul;28(4):363-374. doi: 10.1007/s12192-023-01333-0. Epub 2023 May 11.
4
Identification and validation of autophagy-related genes in Kawasaki disease.川崎病相关自噬基因的鉴定与验证。
Hereditas. 2023 Apr 21;160(1):17. doi: 10.1186/s41065-023-00278-9.
5
Circulating MicroRNAs Identify Early Phenotypic Changes in Sarcomeric Hypertrophic Cardiomyopathy.循环 microRNAs 可识别肌节性肥厚型心肌病的早期表型变化。
Circ Heart Fail. 2023 Jun;16(6):e010291. doi: 10.1161/CIRCHEARTFAILURE.122.010291. Epub 2023 Mar 7.
6
Identification of miRNA profile in the peripheral blood and clinical significance of miR-355 and miR-2911 expression in children with Kawasaki disease.川崎病患儿外周血miRNA谱的鉴定及miR-355和miR-2911表达的临床意义
Am J Transl Res. 2022 Nov 15;14(11):7820-7830. eCollection 2022.
7
MicroRNAs in Kawasaki disease: An update on diagnosis, therapy and monitoring.川崎病相关 microRNAs:诊断、治疗和监测的新进展。
Front Immunol. 2022 Oct 24;13:1016575. doi: 10.3389/fimmu.2022.1016575. eCollection 2022.
8
Amniotic Fluid microRNA in Severe Twin-Twin Transfusion Syndrome Cardiomyopathy-Identification of Differences and Predicting Demise.严重双胎输血综合征心肌病中的羊水微小RNA——差异识别与死亡预测
J Cardiovasc Dev Dis. 2022 Jan 23;9(2):37. doi: 10.3390/jcdd9020037.
9
Epigenetics in Kawasaki Disease.川崎病中的表观遗传学
Front Pediatr. 2021 Jun 25;9:673294. doi: 10.3389/fped.2021.673294. eCollection 2021.